HANLIM PHARM. CO., LTD. is one of leading Korean pharmaceutical manufacturers. Since its establishment in 1974, Hanlim have constantly put the entire effort to develop and provide a wide range of quality products under the company ideology, “To save noble life of a human from various diseases”. Hanlim is continuing long-term investment as technology accumulation and secure advanced research personnel for developing new medicine by establishing a central research lab, and developing advanced medicine will be the core of Hanlim’s vision which will become the foothold for Hanlim to become a global firm. Hanlim not only provides the product information that should be delivered to you but also tries the best to provide more various information and data.
Especially, since medical supply is directly related to life, the final consumer is a patient, not a doctor who selects the medical supply, and provision of unreasonable prizes through by tempting supply purchase means from the cost using public resources can cause more critical damage than other industries. In order to constantly manage society’s faith and credit of total medical supplies, it is necessary to maintain and stimulate impartial, clear, and free competition other than unreasonable sales promotion action in medical supply. In such a view, Hanlim should settle compliance program to prevent action violating fair trade rules as well as thorough compliance to promote realization of clear and fair trade.
Hanlim’s LODIEN Tablet (2.5mg) for coronary artery revascularization and angina:
Hanlim is working under the ideology of “Protecting the precious human life from various forms of disease”. This is the mission of Hanlim. The Hanlim’s LODIEN Tablet (2.5mg) is reducing the risk of coronary artery revascularization. LODIEN (2.5mg) Tablet is used for the diseases such as hypertension, Chronic Stable Angina and Vasospastic Angina.
Hanlim’s LODIEN Tablet (5.0mg) for coronary artery revascularization and angina:
Hanlim constantly put the entire effort to develop medical supplies for treatment to take part in national health improvement. The Hanlim’s LODIEN Tablet (5.0mg) is reducing the risk of hospitalization due to angina. LODIEN (5.0mg) tablet recently diagnosed with CAHD by angiogram and with no heart failure or with more than 40% of cardiac output.
View more: Tablets for Coronary artery revascularization and angina Treatment
